Our results are even more consistent with a study that reported an increased Stroop coefficient of variability with age and in early AD compared to non-early AD patients; this variability also correlated with CSF Aß42 and Tau levels and was accentuated in healthy Apoε-4 carriers [64]. The gene discussed is MAPT; the disease is Alzheimer disease.